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Abstract
Background: Breast cancer is the most common type of malignancy in women worldwide. Euphorbia humifusa
Willd (EuH) is a plant that is widely used as a traditional medicine. However, no systemic studies on the anti-cancer
effects of EuH have been reported. The aim of this study is to evaluate the anti-metastatic effect of the EuH.
Methods: Ethyl acetate fraction was prepared from EuH methanol extracts (EA/EuH). Inhibitory effect of EA/EuH
on cell migration was determined using an in vitro scratch-wound healing assay. The anti-invasive activity
was determined by in vitro three-dimensional spheroid culture system and in vivo syngenic experimental lung
metastasis experiment. Gene expression profiles were analyzed by using RT-PCR, real-time PCR, and luciferase
reporter assay systems.
Results: Ethyl acetate fraction from the EuH extract (EA/EuH) inhibited the migration and invasive capabilities
of highly metastatic MDA-MB-231 breast cancer cells and attenuated syngeneic lung metastasis of mouse 4 T1
breast cancer cells in vivo. Mechanistically, EA/EuH decreased tumor necrosis factor alpha (TNFα)-induced matrix
metalloproteinase (MMP)-9 mRNA expression through the inhibition of NF-κB activity in MDA-MB-231 cells.
Conclusion: EuH may be beneficial in the prevention of invasion and metastasis of early stage breast cancer and
can be served as an anti-metastatic agent or adjuvant therapy against metastatic breast cancer.
Keywords: Euphorbia humifusa Willd, Invasion, Metastasis, Matrix metalloproteinase-9, Tumor necrosis factor alpha,
Nuclear factor-kappa B
Background
Breast cancer is the most common type of malignancy
in women worldwide, accounting for approximately
23 % of total cancer cases and 14 % of total cancer-
related deaths [1]. Breast cancer cells often exhibit high
invasive and metastatic properties. Metastasis is the
uncontrolled spread of primary tumor cells to other sites
in the body and commonly occurs in the late stages of
cancer. Like other cancer types, the prognosis of breast
cancer patients is strongly influenced by the stage of
metastasis.
The tumor microenvironment is the cellular environ-
ment that surrounds the tumor site, and is composed of
extracellular matrix (ECM), blood vessels, and various
cell types, including stromal fibroblasts and infiltrative
immune cells. Tumor necrosis factor alpha (TNFα) is a
pro-inflammatory cytokine involved in the modulation
of systemic inflammation. In the tumor microenviron-
ment, TNFα is produced by tumor cells as well as
tumor-associated cells and plays a central role in pro-
moting tumor invasion and metastasis [2]. During malig-
nant progression, breast epithelial cells undergo a
transition to mesenchymal-type cells (epithelial-to-
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mesenchymal transition). These cells are migratory and
can invade through the surrounding ECM. Matrix metal-
loproteinases (MMPs) are zinc-dependent proteases that
are mainly involved in tissue remodelling via various
physiological and pathological processes that degrade
ECM proteins. Emerging evidence has emphasized the
role of MMPs in migration and invasion of cancer cells
through the breakdown of ECM and basement
membranes [3].
The transcription factor NF-κB regulates many genes
in control of inflammatory responses, cell proliferation,
cell survival, angiogenesis, and metastasis [4]. The NF-
κB family consists of five members, including NF-κB1
(also called p50), NF-κB2 (also called p52), RelA (also
called p65), RelB, and c-Rel [5]. In unstimulated cells,
NF-κB is sequestered in the cytoplasm by the inhibitory
protein IκB, which hinders the nuclear localization of
NF-κB. Upon stimulation of the cells, IκB kinases (IKK)
stimulate NF-κB through the phosphorylation of IκB.
This results in a degradation and dissociation of IκB
from NF-κB leading to the translocation of NF-κB into
the nucleus. In many different types of human cancers, a
constitutively activated NF-κB is common [6]. Aberrant
activation of NF-κB is known to be associated with the
progression of breast cancer [7], particularly the promo-
tion of tumor cell invasion, migration, and metastasis
through the upregulation of MMP-9 expression [8].
Therefore, it seems likely that the inhibition of NF-κB
activity is required for the prevention and treatment of
cancer. It should be noted that several agents inhibiting
NF-κB functions are currently in clinical use or undergo-
ing clinical development as cancer chemotherapeutics
[4, 9–11].
Euphorbia humifusa Willd (EuH), known as Ttang-
Bin-Dae in Korea or Di-Jin-Cao in China, is a dicotyle-
donous, polypetalous plant widely distributed in eastern
Asia. In Korea, EuH has been used as a traditional medi-
cinal plant for the treatment of diarrhoea, jaundice,
dysentery, enteritis, diabetes, and asthma [12, 13]. Previ-
ous phytochemical studies have isolated multiple
bioactive compounds from the EuH, including euphorbino-
side dehydropicrorhiza acid methyl diester, flavone gluco-
sides, apigenin glycosides, tannins, α-pyrrolidinonoids,
lanostane triterpenoids [14–16], exhibiting various pharma-
cological actions, including antifungal, anti-inflammatory,
vasorelaxant, and anti-viral properties [12, 16–18].
However, the effects of EuH on cancer progression,
such as invasion and metastasis, have not been eluci-
dated. In this study, we examined the anti-metastatic
effects of EuH on the highly metastatic human breast
cancer cell line MDA-MB-231. Our results indicate that
EuH inhibits migration, invasion, and experimental
metastasis of MDA-MB-231 cells. Furthermore, EuH re-
duces TNFα-induced MMP-9 expression through the
inhibition of NF-κB activity. The data suggest that EuH
may be beneficial in the prevention of an invasion and
metastasis of early stage breast cancer.
Methods
Cells and chemicals
Human breast carcinoma cells (MDA-MB-231, MDA-
MB-435, T47D, and MCF7) were obtained from the
American Type Culture Collection (ATCC, Manassas,
VA, MD, USA). Mouse mammary carcinoma cells (4 T1)
were kindly provided by Dr. Jeong-Seok Nam (Gwangju
Institute of Science and Technology, Gwangju, Korea).
Cells were grown in Dulbecco’s modified Eagle’s medium
(Corning Cellgro, Manassas, VA, USA) supplemented
with 10 % (v/v) heat-inactivated foetal bovine serum
(Corning Cellgro). TNFα, methanol, n-hexane, chloro-
form, ethyl acetate, n-butanol, dimethylsulfoxide (DMSO),
Tris-base, HEPES, Triton X-100, glycerol, leupeptin, phe-
nylmethylsulfonyl fluoride (PMSF) were purchased from
Sigma-Aldrich (Saint Louis, MO, USA). SDS, acrylamide,
bisacrylamide, ammoniuk persulfate, nitrocellular mem-
branes were from Bio-Rad Laboratories (Hercules, CA,
USA). Pierce™ BCA Protein Assay Reagent was obtained
from Thermo Scientific (Rockford, IL, USA).
Preparation of the E. humifusa Willd extracts
Air dried E. humifusa Willd (EuH) was purchased from
an herbal market from Gyungdong Pharmaceutical
Market (Seoul, Republic of Korea) and taxonomically
identified by a galenical pharmacist, Dr. Hi Jae Cho
(College of Biological Science and Biotechnology,
Konkuk University, Seoul, Republic of Korea). A voucher
specimen was deposited at the College of Biological Sci-
ence and Technology, Konkuk University, Korea. EuH
(3 kg) was soaked in methanol for 3 days. The methano-
lic extract (130 g) was obtained under reduced pressure
using a rotary evaporator. By polarity based fraction-
ation, five fractions were collected from 35.93 g of
methanol extract: n-hexane (10.08 g; 28.1 %), chloroform
(1.36 g; 3.8 %), ethyl acetate (4.91 g; 13.7 %), n-butanol
(8.48 g; 23.6 %), and aqueous fraction (11.12 g; 30.9 %).
Each fraction was dried using a freeze-dryer and
dissolved in DMSO at 10 mg/mL.
Cell migration assay
Migration of MDA-MB-231 cells was determined using
an in vitro scratch-wound healing assay, as described
previously [19]. Migrated cells were photographed with
an EVOS® FL Auto Cell Imaging System (Life Technolo-
gies, Carlsbad, CA, USA). Cells migrated into the gap
area in (A) were quantified in a field of view using
ImageJ software (https://imagej.nih.gov/ij/; Center for
Information Technology, National Institute of Health,
Bethesda, MA, USA).
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Actin reorganization
Polymerized F-actin was examined using the Rhodamine-
phalloidin-based F-Actin Visualization Biochem Kit (Cyto-
skeleton, Inc.; Denver, CO, USA), according to the manu-
facturer’s instructions. Images were captured using an
EVOS FL Auto Cell Imaging System (Life Technologies).
Three-dimensional spheroid culture and invasion assay
Three-dimensional invasion assay was performed using a
Cultrex 3-D Spheroid Cell Invasion Assay kit (Trevigen,
Inc., Gaithersburg, MD, USA), as described previously
[20]. Invasive protrusions into ECM were visualized an
EVOS FL Auto Cell Imaging System.
Syngenic experimental lung metastasis assay
Six-week-old female Balb/c mice were purchased from
YoungBio (Seongnam, Gyeonggi-do, Korea). All animal
experiments were conducted following the standards and
procedures approved by the Konkuk University Institu-
tional Animal Care and Use Committee (No.KU15194).
4 T1 mammary carcinoma cells (6 × 104 cells/50 μL) were
injected into the spleen as described previously [21].
One-day after intra-splenic implantation of tumor
cells, PBS (n = 5) or EA/EuH (10 mg/kg; n = 7) was
administered daily intraperitoneally. Mice were sacri-
ficed after 8 days of cell inoculation, and lung tissues
were stained by routine hematoxylin and eosin
(H&E).
RT-PCR and quantitative real-time PCR
Total RNA was extracted using Isol-RNA lysis reagent
(NucleoZOL; Clontech, Mountain View, CA, USA), and
the synthesis of cDNA was carried out using an iScript
cDNA synthesis kit (Bio-Rad, Hercules, CA, USA). RT-
PCR was performed as described previously [22]. For
quantitative real-time PCR, TaqMan-iQ supermix kit
(Bio-Rad) was used with the Bio-Rad iCycler iQ thermal
cycler according to the manufacturer’s instruction. The
TaqMan fluorogenic probes and gene-specific PCR
primers for MMP-9 and glyceraldehyde-3-phosphate de-
hydrogenase (GAPDH) were described previously [22].
The relative fold changes were normalized to GAPDH
mRNA in the same sample.
NF-κB-dependent transcriptional activity assay
MDA-MB-231 cells were transfected with 0.1 μg of the
5 × NFκB-Luc plasmid, containing five repeats of NF-κB
binding sites and treated with 10 ng/mL TNFα in the ab-
sence and presence of EA/EuH, as described previously
[20]. The luciferase activities were measured with a
Centro LB960 luminometer (Berthold Technologies; Bad
Wildbad, Germany).
Immunoblot analysis
Cells were lysed in 20 mM HEPES (pH 7.2), 1 % (v/v)
Triton X-100, 10 % (v/v) glycerol, 150 mM NaCl,
10 μg/mL leupeptin, and 1 mM PMSF. Protein
extracts (20 μg per sample) were separated via 10 %
SDS-PAGE, transferred to nitrocellulose membranes,
and incubated with appropriate primary and second-
ary antibodies. Primary antibodies against phospho-
IκB (Ser32) and phospho-RelA/p65 (Ser536) were
obtained from Cell Signaling Technology (Beverly,
MA, USA), and an antibody against GAPDH was
from Santa Cruz Biotechnology (Dallas, TX, USA).
The blots were developed using an enhanced chemilumin-
escence detection system (GE Healthcare, Piscataway, NJ,
USA). The relative protein band intensities were deter-
mined using ImageJ software.
Immunofluorescence microscopy
MDA-MB-231 cells plated on coverslips were treated
with or without 10 ng/mL TNFα in the absence and
presence of EA/EuH (5 μg/mL) for 30 min, followed by
fixation, permeabilization, and incubation of primary
antibodies specific to α-tubulin and phospho-p65/RelA
(Ser536) for 2 h, as described previously [23]. Fluores-
cent staining cells were examined under an EVOS FL
fluorescence microscope (Advanced Microscopy Group;
Bothell, WA, USA).
MMP-9 promoter reporter assay
Construction of the MMP-9 promoter reporters, wild-
type pMMP9-Luc(−925/+13) and disrupted NF-κB bind-
ing site pMMP9-Luc(−925/+13)mtNFκB, was described
previously [24]. Transfection of promoter reporters and
luciferase reporter assay were described previously [24].
Luminescence was measured using a Centro LB960 dual
luminometer (Berthold Technologies).
Statistical analysis
All experiments were performed in triplicate. Data are
presented as the mean ± SD. Statistical analysis was per-
formed by one-way ANOVA followed by Sidak’s multiple
comparisons test using GraphPad Prism version 7.0 soft-
ware (GraphPad Software Inc., La Jolla, CA). P-values <
0.05 were considered statistically significant.
Results and discussion
Ethyl acetate fraction of EuH (EA/EuH) inhibits TNFα-
induced motility of MDA-MB-231 breast cancer cells
NF-κB is a transcription factor found in almost all
animal cells and plays a key role in regulating cellular
responses, including immune responses, cell prolifera-
tion, and survival in diverse cell types [25]. Aberrant
activation of NF-κB has been implicated in the progres-
sion of breast cancer [7]. Among the NF-κB family,
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RelA/p65 and p50 complex is the most common
form studied intensively in human cells. Upon stimu-
lation, IκB kinase (IKK) activates NF-κB via the
phosphorylation of the IκB on serine-32, leading to
the proteolysis of IκB. TNFα has been shown to pro-
mote cellular migration in the tumor microenviron-
ment [26]. As TNFα stimulates the IKK in various
cells, we tested the effect of each EuH extract,
including n-hexane, chloroform, ethyl acetate, n-
butanol, and aqueous fraction (each 5 μg/mL), on
TNFα-induced IKK phosphorylation in highly meta-
static MDA-MB-231 human breast cancer cells. Im-
munoblot analysis shows that the ethyl acetate
fraction of EuH (EA/EuH) significantly inhibited
TNFα-induced IKK phosphorylation (P < 0.0001 by
Sidak’s test) (Fig. 1). We choose the EA/EuH for fur-
ther investigation of the anti-metastatic activity.
Cell motility is important for tumor cell invasion and
metastasis. To determine whether EA/EuH inhibits
TNFα-induced migration of highly metastatic MDA-
MB-231 cells, in vitro scratch wound-healing assay was
carried out. After scratching confluent monolayers of
MDA-MB-231 cells to create a wound-like gap, the cells
were treated with TNFα in the absence or presence of
5 μg/mL EA/EuH. TNFα-treated cells efficiently mi-
grated into the gap area compared to untreated cells
(Fig. 2a). However, in the presence of EA/EuH, TNFα-
induced migration of MDA-MB-231 cells was signifi-
cantly inhibited (Fig. 2b; P = 0.0006 by Sidak’s test).
When MDA-MB-231 cells were treated with 5 μg/mL
EA/EuH for 8 h, cell viability was not affected by treat-
ment with EA/EuH (Fig. 2c), suggesting that EA/EuH
effect on the inhibition of cell migration was not due to
its cytotoxicity.
Actin cytoskeletal reorganization plays a key role
in the regulation of cellular movement [27]. During
cell migration, globular actin monomer (G-actin) as-
sembles to form helical filamentous actin (F-actin)
Fig. 1 Effect of E. humifusa Willd (EA/EuH) extracts on TNFα-induced IKK phosphorylation. Serum-starved MDA-MB-231 cells were left untreated
or treated with n-hexane (Hex), chloroform (CH), ethylacetate (EA), n-butanol (Bu), or aqueous (H2O) fraction (each 5 μg/mL) for 30 min before stimulation
with TNFα (10 ng/mL). After 60 min, whole-cell lysates were prepared, and immunoblotting was performed using the phospho-specific antibody against
IKKα/β (Ser176/181). The anti-GAPDH antibody was used as an internal control. Band intensities were analyzed using the ImageJ software. TNFα alone
treated-band intensities were set to 100 % (control). The relative values of % of control were plotted as the mean ± SD. P values were analyzed by Sidak’s
test. (n= 3)
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bundles and networks. To determine whether EA/
EuH affects actin reorganization, F-actin bundle
formation was examined by rhodamine-labelled
phalloidin, a class of phallotoxins that binds select-
ively to F-actin. MDA-MB-231 cells treated with
10 ng/mL TNFα displayed a polarized pattern of F-
actin distributed mostly at cell edge, which was
substantially reduced by 5 μg/mL EA/EuH (Fig. 2d).
These data demonstrate that EA/EuH attenuates
TNFα-induced migratory activity of MDA-MB-231
cells.
EA/EuH inhibits TNFα-induced invasive capability of
MDA-MB-231 breast cancer cells
In addition to cell migration, invasiveness into the sur-
rounding ECM is a critical feature of metastatic cancer
cells. To evaluate the inhibitory effect of EA/EuH on
tumor invasion, 3-D spheroids of MDA-MB-231 cells
were formed in an ECM-like environment and then
monitored for their invasive capability. As shown in
Fig. 3a, the MDA-MB-231 spheroids remained non-
invasive under unstimulated conditions. After 3 days of





Fig. 2 Effect of ethyl acetate fraction of E. humifusa Willd (EA/EuH) on TNFα-induced motility of MDA-MB-231 cells. a Cell migration assay. MDA-
MB-231 cells were treated with or without EA/EuH (5 μg/mL) for 30 min, followed by exposure to TNFα (10 ng/mL). After 8 h, the representative
field images were captured by an EVOS FL Auto Cell Imaging System. Dotted lines indicate the scraped boundaries at the beginning of the
experiment. b Cells migrated into the gap area were quantified in a field of view using ImageJ software. The data shown represent the mean ± SD
(n = 3). P value was analyzed by Sidak’s test. c Cell viability assay. MDA-MB-231 cells were treated with or without EA/EuH (5 μg/mL) for 30 min,
followed by addition of TNFα (10 ng/mL). After 8 h, viable cells were determined using a Cell Counting Kit-8 (CCK-8). The data shown represent the
mean ± SD. P value was analyzed by Sidak’s test. ns, not-significant. d MDA-MB-231 cells were treated with or without EA/EuH (5 μg/mL) for 30 min,
followed by exposure to TNFα (10 ng/mL). After 12 h, the cells were stained with rhodamine-phalloidin (1:100) for 1 h and actin rearrangement was
analyzed. Arrows indicate polarized F-actin
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out of the spheroid into the surrounding matrix with a
typical starburst pattern. However, in the presence of
5 μg/mL EA/EuH, TNFα-induced invasive protrusion was
almost absent. These data suggest that EA/EuH could in-
hibit the invasive capability of breast cancer cells.
EA/EuH reduces experimental lung metastasis of 4 T1
mouse mammary tumor cells in vivo
We next investigated whether EA/EuH inhibits tumor
metastasis in vivo. Since tumor metastatic progression is
strongly influenced by host immune responses and the
interaction of tumor cells with tumor microenviron-
ment, we employed a mouse syngeneic tumor metastasis
model. 4 T1 mouse mammary carcinoma cells are highly
invasive and can metastasize to multiple sites, including
the lung [28]. We implanted 4 T1 cells into the spleen
of Balb/c mouse (n = 15), and they were allowed to form
tumors. After 1 day, we randomized the mice into two
groups, with one control group receiving phosphate
buffered saline (PBS) (n = 5) and the other receiving
10 mg/kg EA/EuH (n = 7) daily by intraperitoneal injec-
tion. Eight days after implantation, all mice were sacri-
ficed. As shown in Fig. 3b, mice that received EA/EuH
showed smaller metastatic foci in the lungs as compared
to control group mice. These data suggest that EA/EuH
has a potent inhibitory effect against experimental lung
metastasis.
EA/EuH suppresses TNFα-induced MMP-9 mRNA
expression
For migration and invasion of tumor cells, proteolytic
disruption of basement membranes and ECM proteins is
Fig. 3 Inhibitory effect of EA/EuH on the invasive capability of MDA-MB-231 cells and experimental lung metastasis of 4 T1 cells. a MDA-MB-231
cell spheroids in the extracellular matrix were either untreated (control) or treated with TNFα (10 ng/mL) in the absence or presence of EA/EuH
(5 μg/mL). Morphology of 3-D cell invasion was captured at 3-days and 7-days with an EVOS FL Auto Cell Imaging System. b Mouse 4 T1 mam-
mary tumor cells were implanted into the spleen of Balb/c mouse. At 1 day post intra-splenic implantation of 4 T1 cells, either phosphate buff-
ered saline (PBS) or EA/EuH (10 mg/kg) was administered intraperitoneally daily. After 8 days, mice were sacrificed. Lung tissues were fixed and
stained with hematoxylin and eosin (H&E)
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critical [3]. MMP-9 degrades collagen in the basement
membrane and ECM. MMP-9 levels are closely linked to
the promotion of tumor invasion and metastasis, and
specific inhibitors of MMP have been shown to inhibit
tumor cell invasion [29]. Indeed, MMP-9 is overex-
pressed in breast cancers and is associated with the pro-
motion of metastasis [30].
Given that TNFα induces MMP-9 expression in many
types of cancer [31, 32], we wondered whether EA/EuH
inhibits TNFα-induced expression of MMP-9 in various
breast cancer cells. RT-PCR analysis showed that treat-
ment with 10 ng/mL TNFα upregulated MMP-9 mRNA
expression in MDA-MB-231, MDA-MB-435, T47D, and
MCF7 human breast cancer cells, while this induction
was substantially abolished in the presence of 5 μg/mL
EA/EuH (Fig. 4a). To precisely quantify the changes in
MMP-9 mRNA expression, quantitative real-time PCR
analysis was performed (Fig. 4b). Treatment with 10 ng/
mL TNFα alone resulted in 330 ± 65.6-, 313 ± 35.1-, 186 ±
61.2, and 233 ± 56.9-fold increases in MMP-9 mRNA
levels in MDA-MB-231, MDA-MB-435, T47D, and MCF7
cells, respectively. However, these were significantly
decreased to 75.7 ± 27.2-, 35.0 ± 8.89-, 16.3 ± 7.57-,
and 22.7 ± 9.71-fold increases upon pre-treatment with
5 μg/mL EA/EuH, respectively (all P < 0.01 by Sidak’s
test). These data suggest that EA/EuH can downregu-
late TNFα-induced MMP-9 mRNA expression in
various breast cancer cells.
EA/EuH inhibits TNFα-induced MMP-9 expression at the
promoter level
To understand the molecular mechanism underlying
EA/EuH-induced downregulation of MMP-9 mRNA
expression, we examined the effect of EA/EuH on
Fig. 4 Inhibitory effect of EA/EuH on TNFα-induced MMP-9 mRNA expression. a RT-PCR. MDA-MB-231, MDA-MB-435, T47D, and MCF7 cells were
treated with or without TNFα (10 ng/mL) in the absence of presence of EA/EuH (5 μg/mL) for 18 h. Total RNA was isolated and then RT-PCR was
performed. GAPDH mRNA was used as an internal control. b Real-time PCR. MDA-MB-231, MDA-MB-435, T47D, and MCF7 cells were treated as in
(a). MMP-9 mRNA levels were measured by quantitative real-time PCR. The relative fold changes were normalized to GAPDH mRNA in the same
sample. The data shown represent the mean ± SD (n = 3). ***, P < 0.0001. P value was analyzed by Sidak’s test
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Fig. 5 Inhibitory effect of EA/EuH on TNFα-induced MMP-9 promoter activation. a Promoter assay. MDA-MB-231 cells were transfected with
0.2 μg of promoter reporter, pMMP9-Luc(−925/+13). After 48 h, cells were treated with Ea/EuH (5 μg/mL) for 8 h, and their luciferase activities
were measured. Firefly luciferase activity was normalized to Renilla luciferase activity. The data shown represent the mean ± SD (n = 9).
***, P < 0.0001. P value was analyzed by Sidak’s multiple comparisons test. b Either pMMP9-Luc(−925/+13) or pMMP9-Luc(−925/+13)mtNFκB was
transfected into MDA-MB-231 cells. After 48 h, cells were treated with TNFα (10 ng/mL) for 8 h, and their luciferase activities were measured. The data
shown represent the mean ± SD (n = 9). P value was analyzed by Sidak’s test. c Either pMMP9-Luc(−925/+13) or pMMP9-Luc(−925/+13)mtNFκB was
co-transfected along with RelA/p65 nuclear factor kappa B (NF-κB) expression plasmid into MDA-MB-231 cells. After 48 h, cells were collected, and their
luciferase activities were measured. The data shown represent the mean ± SD (n = 9). ns, not significant. ***, P < 0.0001. P value was analyzed by Sidak’s
multiple comparisons test
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MMP-9 gene promoter activity. MDA-MB-231 cells
were transfected with MMP-9 promoter reporter,
pMMP9-Luc(−925/+13), and the luciferase reporter
activity was assessed. We found that TNFα-induced
MMP-9 promoter activity was significantly inhibited
in a dose-dependent manner by 5 μg/mL EA/EuH
treatment (all P < 0.0001 by Sidak’s test; Fig. 5a),
indicating that EA/EuH reduced MMP-9 expression
at the transcriptional level. The MMP-9 gene is
regulated by multiple regulatory proteins, including
NF-κB [32]. We also found that disruption of the
NF-κB-binding site by site-directed mutagenesis ab-
rogated TNFα-induced MMP-9 gene promoter activ-
ity (Fig. 5b) and RelA/p65 NF-κB-induced MMP-9
gene promoter activity (Fig. 5c). Thus, it is possible
that EA/EuH-induced downregulation of MMP-9
expression is associated with the inhibition of NF-κB
transcriptional activity.
EA/EuH attenuates TNFα-induced NF-κB activation
To investigate whether EA/EuH could inhibit NF-κB,
MDA-MB-231 cells were treated with 10 ng/mL TNFα
for 20 min in the absence or presence of EA/EuH. Phos-
phorylation status of IκB and RelA/p65 NF-κB was ana-
lyzed by immunoblot analysis. Treatment with EA/EuH
dose-dependently inhibited TNFα-induced phosphoryl-
ation of IκB on serine-32 and RelA/p65 on serine-536
(Fig. 6a), suggesting that EA/EuH blocked the signaling
pathway regulating IκB upstream kinase. To address fur-
ther the inhibitory effect of EA/EuH on NF-κB, RelA/
p65 phosphorylation was analyzed in MDA-MB-231
cells using immunofluorescent microscopy. Fluorescent
Fig. 6 Inhibitory effect of EA/EuH on TNFα-induced NF-κB activation. a Serum-starved MDA-MB-231 cells were pre-treated with EA/EuH (5 μg/mL)
for 30 min before stimulation with TNFα (10 ng/mL). After 20 min, whole-cell lysates were prepared, and immunoblotting was performed using
the phospho-specific antibody against IκBα (Ser32) or RelA/p65 (Ser536) as indicated. The anti-GAPDH antibody was used as an internal control.
b MDA-MB-231 cells were pre-treated with EA/EuH (5 μg/mL) for 30 min before stimulation with TNFα (10 ng/mL). After 20 min, the cells were fixed
and incubated with antibodies against α-tubulin or phospho-RelA/p65 (Ser536) for 2 h, followed by incubation with Alexa Fluor 488-conjugated (green
signal) or Alexa Fluor 555-conjugated (red signal) secondary antibody for 30 min. Nuclear DNA was stained with 1 μg/mL Hoechst 33258 for 10 min
(blue signal). c MDA-MB-231 cells were transfected with 5× NFκB-Luc plasmid along with 50 ng pRL-null. At 48 h post-transfection, the cells were
treated with or without 10 ng/mL TNFα in the absence or presence of EA/EuH (5 μg/mL). The data shown represent the mean ± SD. ***, P < 0.0001
(n = 9). P value was analyzed by Sidak’s multiple comparisons test
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staining for phospho-RelA at serine-536 was evident in
the perinucleus and nucleus upon TNFα stimulation,
which was suppressed by EA/EuH treatment (Fig. 6b).
We next wondered whether EA/EuH-induced inhibition
of NF-κB phosphorylation is functionally linked to the
inhibition of transcriptional activity. NF-κB-dependent
transcription was measured using a NF-κB cis-acting
luciferase report system. Upon 10 ng/mL TNFα stimula-
tion, NF-κB transcriptional activity was increased 9.3 ±
1.5-fold; however, this increase in transcriptional activity
was significantly decreased in the presence of 5 μg/mL
EA/EuH (all P < 0.0001 by Sidak’s test; Fig. 6c), suggesting
that EA/EuH inhibits NF-κB-regulated gene transcription.
Conclusion
E. humifusa Willd has been used in traditional medicine
in the eastern Asia, including Korea and China, for a
long time. This study demonstrates that the ethyl acetate
fraction from E. humifusa Willd (EA/EuH) has a pre-
ventive effect on TNFα-induced invasive capability of
highly metastatic MDA-MB-231 breast cancer cells
through the inhibition of NF-κB-mediated MMP-9 gene
expression. We also show that EA/EuH attenuated ex-
perimental lung metastasis in vivo as revealed by syn-
genic intra-splenic transplantation model of 4 T1 mouse
mammary carcinoma cells. These findings suggest that
E. humifusa Willd may be beneficial in the prevention of
invasion and metastasis of early stage breast cancer.
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